CJC-1295

CJC-1295 is a synthetic analog of growth hormone–releasing hormone (GHRH) engineered to enhance stability and receptor interaction in experimental models. It is studied for its binding to GHRH receptors and modulation of somatotropic axis signaling pathways. Preclinical research utilizes CJC-1295 to investigate receptor activation kinetics, intracellular signaling cascades, and peptide-mediated regulation of growth hormone pathways under controlled laboratory conditions.

For research use only. Not for human consumption.